Tempest Therapeutics (TPST) had the highest return between September 1, 2023 and October 31, 2023 by a US stock, returning 666.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Tempest Therapeutics (TPST) | 9/1/2023 - 10/31/2023 | 666.36% |
Soleno Therapeutics (SLNO) | 9/1/2023 - 10/31/2023 | 380.85% |
Ainos (AIMDW) | 9/1/2023 - 10/31/2023 | 370% |
Golden Heaven Group Holdings Ltd Ordinary Shares (GDHG) | 9/1/2023 - 10/31/2023 | 328.8% |
Palladyne AI (PDYNW) | 9/1/2023 - 10/31/2023 | 247.78% |
Femasys (FEMY) | 9/1/2023 - 10/31/2023 | 244.19% |
SHF (SHFSW) | 9/1/2023 - 10/31/2023 | 239.51% |
LMF Acquisition Opportunities (ICU) | 9/1/2023 - 10/31/2023 | 215.77% |
Acurx Pharmaceuticals LLC (ACXP) | 9/1/2023 - 10/31/2023 | 174.36% |
LMF Acquisition Opportunities (ICUCW) | 9/1/2023 - 10/31/2023 | 174.07% |
error (ZVZZT) | 9/1/2023 - 10/31/2023 | 165.35% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 9/1/2023 - 10/31/2023 | 160.25% |
OUTLOOK THERAPEUTICS (OTLK) | 9/1/2023 - 10/31/2023 | 158.06% |
EUDA Health (EUDAW) | 9/1/2023 - 10/31/2023 | 148.9% |
E-Home Household Service (EJH) | 9/1/2023 - 10/31/2023 | 121.98% |
Global Mofy Metaverse Limited Ordinary Shares (GMM) | 9/1/2023 - 10/31/2023 | 115.2% |
Northann (NCL) | 9/1/2023 - 10/31/2023 | 112.8% |
Barinthus Biotherapeutics (BRNS) | 9/1/2023 - 10/31/2023 | 112.12% |
Cybin (CYBN) | 9/1/2023 - 10/31/2023 | 108.71% |
Oncology Institute (TOIIW) | 9/1/2023 - 10/31/2023 | 99.86% |
enGene Holdings Inc Common Stock (ENGN) | 9/1/2023 - 10/31/2023 | 99.13% |
Immunitybio (IBRX) | 9/1/2023 - 10/31/2023 | 93.83% |
IRIDEX (IRIX) | 9/1/2023 - 10/31/2023 | 93.51% |
Globus Maritime (GLBS) | 9/1/2023 - 10/31/2023 | 88.51% |
Scholar Rock (SRRK) | 9/1/2023 - 10/31/2023 | 87.86% |
